WeightControl.com Interview with:
Mette Bliddal
Lektor, ph.d
Department of Clinical Research
Associate Professor, KI, OUH, Research unit of Gynaecology and Obstetrics
University of Southern Denmark
WeightControl.com: What is the background for this study?
Response: We began noticing that more new mothers were starting weight-loss medication shortly after giving birth. Once semaglutide was approved for weight loss, the numbers rose fast. That caught our attention, especially because so little is known about using these medications during a time of major physical and hormonal changes, natural weight loss, and breastfeeding, and because the effects on breastfed infants remain unclear. This made it important to understand how common this use has already become.